Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

FNZ employee shareholders told success more likely
Finance

FNZ employee shareholders told success more likely

Account show loss at global fintech widens. 

Victoria Young 05 Jun 2025
NZ Super ahead of the curve on US equities
Finance

NZ Super ahead of the curve on US equities

New Zealand’s sovereign wealth fund has been overweight in European equities.

Gregor Thompson 03 Jun 2025
Former Telecom chair Wayne Boyd honoured
Finance

Former Telecom chair Wayne Boyd honoured

Honours recognition for a lifetime of low-key, high-quality leadership.

Pattrick Smellie 02 Jun 2025
Andrew Barclay to leave Goldman Sachs NZ
Finance

Andrew Barclay to leave Goldman Sachs NZ

Andrew Barclay has been one of NZ’s most respected deal-makers.

Pattrick Smellie 20 May 2025